BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 22261239)

  • 1. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of protective antibody titers for canine distemper virus and canine parvovirus in dogs entering a Florida animal shelter.
    Lechner ES; Crawford PC; Levy JK; Edinboro CH; Dubovi EJ; Caligiuri R
    J Am Vet Med Assoc; 2010 Jun; 236(12):1317-21. PubMed ID: 20550446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two assays for detection of antibodies against canine parvovirus and canine distemper virus in dogs admitted to a Florida animal shelter.
    Gray LK; Crawford PC; Levy JK; Dubovi EJ
    J Am Vet Med Assoc; 2012 May; 240(9):1084-7. PubMed ID: 22515628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of a point-of-care ELISA test kit for predicting the presence of protective canine parvovirus and canine distemper virus antibody concentrations in dogs.
    Litster AL; Pressler B; Volpe A; Dubovi E
    Vet J; 2012 Aug; 193(2):363-6. PubMed ID: 22381707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
    Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
    BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
    Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
    J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Community's Risk for Canine Parvovirus and Distemper Using Antibody Testing and GIS Mapping of Animal Shelter Intakes.
    Spindel ME; Krecic MR; Slater MR; Vigil N
    J Appl Anim Welf Sci; 2018; 21(4):362-374. PubMed ID: 29557180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a dot enzyme-linked immunosorbent assay for evaluation of the immune status to canine parvovirus and distemper virus in adult dogs before revaccination.
    Waner T; Mazar S; Keren-Kornblatt E
    J Vet Diagn Invest; 2006 May; 18(3):267-70. PubMed ID: 16789715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of serum antibody titers against canine distemper virus and canine parvovirus in dogs hospitalized in an intensive care unit.
    Mahon JL; Rozanski EA; Paul AL
    J Am Vet Med Assoc; 2017 Jun; 250(12):1413-1418. PubMed ID: 28569640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
    Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
    Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vaccination with recombinant canine distemper virus vaccine immediately before exposure under shelter-like conditions.
    Larson LJ; Schultz RD
    Vet Ther; 2006; 7(2):113-8. PubMed ID: 16871493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
    Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment of a point-of-care assay to determine protective vaccinal antibody titers to canine viral diseases.
    Ad Y; Halperin IM; Olstad EC; Gershwin LJ; Sullivan L; Reagan KL
    Vet J; 2023; 298-299():106017. PubMed ID: 37524148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
    Pardo MC; Bauman JE; Mackowiak M
    Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination at different anatomic sites induces different levels of the immune responses.
    Jin H; Xu Y; Shi F; Hu S
    Res Vet Sci; 2019 Feb; 122():50-55. PubMed ID: 30453180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
    Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
    Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.